Golin/Harris International
New tool to improve patient understanding of long-acting injectable antipsychotic therapies LAT unveiled in April issue of Psychiatry 2009
Published in Drug Law Weekly, June 9th, 2009
Nonadherence to oral antipsychotic medications is one of the most significant clinical challenges in psychiatry and behavioral medicine, with rates of nonadherence estimated to be as high as 50 and 75 percent in the first and second years of treatment.2,3 Despite evidence suggesting that continuous antipsychotic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-06-09)
More Articles from Drug Law Weekly
- Addiction Medicine
New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction - Adverse Drug Reactions
Researchers from Teikyo University, Medical Department discuss findings in adverse drug reactions - Angiology
New findings reported from S.S. Agarwal and co-authors describe advances in angiology - Bureau of Alcohol, Tobacco, Firearms and Explosives
Two Subjects Arrested for Solicitation to Commit Capital Murder - Burke, Mahoney & Wise
$12 Million Settlement in Birth Injury Lawsuit Against OSF Healthcare, Announces Burke, Mahoney & Wise - Campaign for Tobacco-Free Kids
New Maine Poll: Voters Strongly Support FDA Regulation of Tobacco Products - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
